BioCentury
ARTICLE | Clinical News

Sancuso granisetron patch regulatory update

April 30, 2012 7:00 AM UTC

The European Commission approved an MAA from Kyowa's ProStrakan Group plc subsidiary for Sancuso granisetron to prevent nausea and vomiting associated with moderately or highly emetogenic chemotherap...